Shares of Coca-Cola (NYSE: KO) were falling today over concerns that weight-loss drugs like Ozempic and Wegovy are leading customers to buy fewer groceries and consume fewer calories. Walmart's U.S. CEO John Furner told Bloomberg that the drugs are leading to a "slight pullback in overall basket." The news prompted a sell-off in the soft drink industry, with Coca-Cola finishing down 4.8%.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles